RB780 Mouse Anti-Human CD19
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development
Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram
Figures and data in A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking | eLife
International Clinical Cytometry Society
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma | Nature Medicine
REAlease® CD19 MicroBead Kit, human | B cells | MicroBeads and Isolation Kits | Cell separation reagents | MACS Cell Separation | Products | Miltenyi Biotec | Australia
CD79a surface staining: a useful marker of mature B cells - EXBIO Antibodies
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy - Gao - Cytometry Part B: Clinical Cytometry - Wiley Online Library
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
Table 2 from The role of CD 20 and CD 19 with their flow cytometric parameters in differentiation between Chronic Lymphocytic Leukaemia / Small Lymphocytic Lymphoma and other B-cell Non Hodgkin Lymphoma | Semantic Scholar
Cells | Free Full-Text | Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression
B Cells
Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram
Rat CD19 Antibody AF7489: R&D Systems
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
View Image
Immunophenotyping of B Cells by Flow Cytometry | Bio-Rad
A Guide to B Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
